OR HB2385

Prohibits drug manufacturers from denying, restricting, or interfering with 340B covered entities' ability to acquire, receive delivery of, or dispense discounted drugs through contracted pharmacies in Oregon

Bars manufacturers from requiring covered entities to submit claims or utilization review data as a condition for accessing 340B drugs, unless required by the U.S. Department of Health and Human Services

Authorizes the State Board of Pharmacy to impose civil penalties up to $5,000 per day per violation against manufacturers who violate these provisions

Penalty revenues deposited into the State Board of Pharmacy Account

Takes effect 91 days after the 2025 legislative session adjourns